ATOM: the cash flow

MyFinsight

For the year ending 2025-12-31, ATOM had -$6,568K decrease in cash & cash equivalents over the period. -$14,920K in free cash flow.

Cash Flow	2025-12-31
Net loss	-20,174
Depreciation and amortization	48
Operating lease right of use asset amortization	252
Financing lease right of use asset amortization	937
Stock-based compensation	4,963
Accretion of discounts on available-for-sales securities	-6
Accounts receivable	-6
Unbilled contracts receivable	0
Interest receivable	-20
Prepaid expenses and other current assets	7
Accounts payable	115
Accrued expenses	-71
Accrued payroll expenses	-678
Operating lease liability	-279
Deferred revenue	3
Net cash used in operating activities	-14,871
Acquisition of property and equipment	49
Purchase of available-for-sale securities	0
Maturity of available-for-sale securities	1,000
Net cash provided by investing activities	951
Proceeds from at-the-market sale of stock, net of commissions and expenses	7,611
Proceeds from exercise of stock options	905
Proceeds from stock sales	0
Payments of principal for financing lease	1,164
Net cash provided by financing activities	7,352
Net increase (decrease) in cash and cash equivalents	-6,568
Cash and cash equivalents at beginning of year	25,778
Cash and cash equivalents at end of year	19,210

Unit: Thousand (K) dollars (except for numbers of shares and EPS).